about
The Role of Galectin-3 in the KidneysState of the Art: Newer biomarkers in heart failureClinical Correlates and Prognostic Value of Plasma Galectin-3 Levels in Degenerative Aortic Stenosis: A Single-Center Prospective Study of Patients Referred for Invasive TreatmentUsefulness of combining galectin-3 and BIVA assessments in predicting short- and long-term events in patients admitted for acute heart failure.Regulation of ozone-induced lung inflammation and injury by the β-galactoside-binding lectin galectin-3.Galectin-3, Renal Function, and Clinical Outcomes: Results from the LURIC and 4D StudiesGalectin 3: association to neurohumoral activity, echocardiographic parameters and renal function in outpatients with heart failure.Galectin-3 Blockade Reduces Renal Fibrosis in Two Normotensive Experimental Models of Renal DamageCirculating Galectin-3 Is Associated With Cardiometabolic Disease in the Community.Galectin-3 Is Elevated and Associated With Adverse Outcomes in Patients With Single-Ventricle Fontan Circulation.Galectin-3 Is Associated with Restrictive Lung Disease and Interstitial Lung Abnormalities.Incorporating common biomarkers into the clinical management of heart failureRenocardiovascular Biomarkers: from the Perspective of Managing Chronic Kidney Disease and Cardiovascular Disease.New therapeutic strategies under development to halt the progression of renal failure.Novel renal biomarkers to assess cardiorenal syndromeGalectin-3 Serum Levels Are Independently Associated With Microalbuminuria in Chronic Heart Failure Outpatients.Long-term sequelae from acute kidney injury: potential mechanisms for the observed poor renal outcomes.Cardiovascular biomarkers and sex: the case for women.Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation.ST2 and Galectin-3: Ready for Prime Time?Heart failure with preserved ejection fraction: a nephrologist-directed primer.Diagnostic and prognostic value of galectin-3, serum creatinine, and cystatin C in chronic kidney diseases.Plasma galectin-3 levels are associated with the risk of incident chronic kidney disease.Predictive Value for Galectin 3 and Cardiotrophin 1 in Hemodialysis Patients.Serum galectin-3 levels were associated with proteinuria in patients with Familial Mediterranean Fever.Differences in galectin-3, a biomarker of fibrosis, between participants with peripheral artery disease and participants with normal ankle-brachial index.Pharmacological inhibition of galectin-3 protects against hypertensive nephropathy.Prognostic value of sST2 and galectin-3 for death relative to renal function in patients hospitalized for heart failure.Cardiac dysfunction in Pkd1-deficient mice with phenotype rescue by galectin-3 knockout.Galectin-3 and new-onset CKD: marker or mediator?Methods for the detection and serum depletion of porcine galectin-3.Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review).Prospective Validation of a Screening Biomarker Approach Combining Amino-Terminal Pro-Brain Natriuretic Peptide With Galectin-3 Predicts Death and Cardiovascular Events in Asymptomatic Hemodialysis Patients.Galectin-3 levels are associated with right ventricular functional and morphologic changes in pulmonary arterial hypertension.
P2860
Q26752754-59FDCCD4-FB97-4684-9106-1BCF55824AD5Q27027899-B3173E60-0593-40D3-B765-49371BEACF3FQ33754895-81965336-7BCB-4B8A-8711-1D0B7458026FQ33912126-D9483D51-7A3F-4F8E-AF5B-BA25CCA2D3F3Q35533394-BA87BCFB-9006-4A84-A68B-D394CEF47FB2Q36003071-36BF468C-B803-4093-9C83-B93377513190Q36035702-08CBF99A-DC7C-4845-BD2A-9FA69FEE4E9CQ36187612-5CC64856-624A-42E1-9351-DED6AC7E6B28Q36877555-A4EEA9CE-FC93-4186-A25E-8F50631353D3Q36877769-53A68CDB-965A-49E1-95B5-219022697B2BQ37125501-38782A51-DBD2-4EF3-B9C1-826A6843F97DQ37347009-F69698BE-FA5E-4567-8B7E-4F85354B9D8FQ37681556-01ADE747-528D-4800-A065-755184B00153Q38201504-20AFB440-4BF6-40CF-8743-CCB232654D55Q38252731-E8B28130-D9F4-4E10-B1C9-F114B8216D76Q38309028-0C5B5627-2577-41DD-9A46-48A32AA1DF3BQ38426618-496167EA-E790-4B16-BA42-7631AC210712Q38543356-5C1F908F-FAF1-4741-A905-9E1318CF1AF7Q38727741-5E140033-04D2-49D0-BFCD-26B63732CB65Q38816590-F3E86C52-0702-4800-BC34-7115091C5A06Q39301622-8A62F526-5590-42FD-91BE-72A32CE3FFB8Q39303610-EB762568-2DDC-4722-B6B6-0AA3393533FEQ40060474-755CC0FE-E8AC-4C99-BF9D-88C1CB763FABQ40085529-AB5A1A72-4161-4BCD-AC02-6C45EA0D0CA4Q40199201-6AB59506-0DA6-4C38-83A1-0BD7D3F93B4AQ40765198-EC745079-8AC0-4B58-A60A-6649A26A800EQ41695164-594848BC-B285-41CB-BFC3-A762F47E4761Q41731823-5F1AE6D6-A0A2-4222-A9C2-02C76F3A5E09Q42359246-E2885429-D345-4149-9A0A-787869FD06BCQ42569059-D9925938-372D-416D-AFBB-29D4F29283A1Q45992912-C115738D-AB9F-4FFF-95B7-EF0EC21FBE09Q47329197-C71D4B7A-A10E-4B04-96A3-9D9E48B8867AQ48035139-79A05D5A-3519-4BA0-8255-3CFC9C4B0014Q53506123-38913292-A603-49F8-B86C-499F227E9033
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Elevated galectin-3 precedes the development of CKD
@en
Elevated galectin-3 precedes the development of CKD.
@nl
type
label
Elevated galectin-3 precedes the development of CKD
@en
Elevated galectin-3 precedes the development of CKD.
@nl
prefLabel
Elevated galectin-3 precedes the development of CKD
@en
Elevated galectin-3 precedes the development of CKD.
@nl
P2093
P2860
P356
P1476
Elevated galectin-3 precedes the development of CKD
@en
P2093
Caroline S Fox
Conall M O'Seaghdha
Daniel Levy
Shih-Jen Hwang
P2860
P304
P356
10.1681/ASN.2012090909
P577
2013-06-13T00:00:00Z